Band 8+: WRITING TASK 2 You should spend about 40 minutes on this task. Write about the following topic: Many people in poor countries die from diseases that are curable because they cannot afford the medication required. Do you believe that drug companies should make their products available at reduced prices in these countries? Give reasons for your answer and include any relevant examples from your own knowledge and experience. Write at least 250 words.

In addressing the question of whether drug companies should make their products available at reduced prices in poor countries where curable diseases claim many lives due to unaffordable medication, I firmly believe that such companies bear a moral responsibility to prioritize accessibility over profits.

In impoverished nations, individuals often face a tragic reality where treatable diseases become fatal due to the inability to afford essential medications. This raises a compelling humanitarian concern that pharmaceutical companies should address. Health is a fundamental human right, and by offering medications at reduced prices, these companies can play a pivotal role in saving lives and mitigating the devastating impact of diseases in economically challenged regions.

For example, the provision of low-cost antiretroviral drugs in sub-Saharan Africa has demonstrated the positive impact of affordability on widespread treatment for HIV/AIDS. Collaborations between pharmaceutical companies and global health initiatives showcase the transformative potential of accessible medications.

Reducing the prices of medications in impoverished countries not only aligns with humanitarian values but also presents long-term benefits for both the affected populations and the pharmaceutical companies. A healthier population is more likely to contribute productively to society, breaking the cycle of poverty and potentially creating future markets for pharmaceutical products.

Take, for instance, the positive outcomes of providing discounted vaccines for preventable diseases. This not only saves lives but also contributes to overall societal development. Children who receive timely vaccinations are more likely to grow into healthy adults, capable of participating in economic activities and positively impacting their communities.

In conclusion, the ethical imperative for pharmaceutical companies to make their products available at reduced prices in poor countries is clear. By doing so, these companies not only address immediate health crises but also lay the foundation for a healthier, more prosperous global community. The true measure of success for pharmaceutical companies lies not only in financial gains but in the positive impact they can make on the well-being of humanity.